Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Blood|July 14, 2019
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphomaCiara L Freeman, Robert Kridel, Alden A Moccia, et al.
Journal of Hematopathology|November 16, 2024
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factorsWilliam Patrick Morrow, Nicholas S Milligan, Robert S Ohgami, et al.
European Journal of Haematology|December 23, 2016
IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case seriesMollie N Carruthers, Sujin Park, Graham W Slack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell LymphomaMatthew J Maurer, Fredrik Ellin, Line Srour, et al.
American Journal of Clinical Pathology|April 24, 2012
B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphomaAli Bashashati, Nathalie A Johnson, Alireza Hadj Khodabakhshi, et al.
Blood Advances|September 8, 2022
The outcome of older adults with classic Hodgkin lymphoma in British ColumbiaPhoebe T M Cheng, Diego Villa, Alina S Gerrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2024
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphomaMichael Y Li, Lauren C Chong, Gerben Duns, et al.
Blood|April 13, 2012
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphomaDavid W Scott, Karen L Mungall, Susana Ben-Neriah, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Pageof 9